Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer

[1]  Tatsuya Higashi,et al.  Clinical value of manual fusion of PET and CT images in patients with suspected recurrent colorectal cancer. , 2007, AJR. American journal of roentgenology.

[2]  F. Granath,et al.  Loco-regional Recurrence from Colon Cancer: A Population-based Study , 2007, Annals of Surgical Oncology.

[3]  M. Stamos,et al.  The Role of Carcinoembryonic Antigen as a Predictor of the Need for Preoperative Computed Tomography in Colon Cancer Patients , 2006, The American surgeon.

[4]  Catherine Julié,et al.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  S. Singhvi,et al.  An audit of fusion CT-PET in the management of colorectal liver metastases. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  A. Lacy,et al.  Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  E. Glatstein.  Detection of Recurrence in Patients With Rectal Cancer: PET/CT After Abdominoperineal or Anterior Resection , 2006 .

[8]  W. Oyen,et al.  The impact of fluor‐18‐deoxyglucose‐positron emission tomography in the management of colorectal liver metastases , 2005, Cancer.

[9]  E. Van Cutsem,et al.  Progress in the adjuvant treatment of colon cancer: has it influenced clinical practice? , 2005, JAMA.

[10]  Bruce D Minsky,et al.  Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  J. Faivre,et al.  Improvement in colorectal cancer survival: a population-based study. , 2005, European journal of cancer.

[12]  M. Steinling,et al.  Prospective evaluation of the impact of [18F]fluoro‐2‐deoxy‐D‐glucose positron emission tomography of resectable colorectal liver metastases , 2005, The British journal of surgery.

[13]  B. Siegel,et al.  Five-Year Survival After Resection of Hepatic Metastases From Colorectal Cancer in Patients Screened by Positron Emission Tomography With F-18 Fluorodeoxyglucose (FDG-PET) , 2004, Annals of surgery.

[14]  J. Fleshman,et al.  Liver resection for colorectal metastases. , 2004, Annals of the Royal College of Surgeons of England.

[15]  E. Fishman,et al.  Incremental value of CT in PET/CT of patients with colorectal carcinoma , 2004, Abdominal Imaging.

[16]  R. Wahl,et al.  Direct Comparison of 18F-FDG PET and PET/CT in Patients with Colorectal Carcinoma , 2003 .

[17]  C. Earle,et al.  Follow-up of patients with curatively resected colorectal cancer: a practice guideline , 2003, BMC Cancer.

[18]  J. Meyerhardt,et al.  Follow-up strategies after curative resection of colorectal cancer. , 2003, Seminars in oncology.

[19]  R. Wahl,et al.  Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  G. Ravera,et al.  Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. , 2002, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[21]  W. Oyen,et al.  Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[22]  E. Pauwels,et al.  Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIb: Therapy response monitoring in colorectal and lung tumours, head and neck cancer, hepatocellular carcinoma and sarcoma. , 2001, Journal of cancer research and clinical oncology.

[23]  E. Pauwels,et al.  Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose in oncology. Part IIIa: Therapy response monitoring in breast cancer, lymphoma and gliomas. , 2001, Journal of cancer research and clinical oncology.

[24]  R. Costi,et al.  Role of follow-up in management of local recurrences of colorectal cancer , 1998, Diseases of the colon and rectum.

[25]  T. Fleming,et al.  Surgery for Recurrent Colon Cancer: Strategies for Identifying Resectable Recurrence and Success Rates after Resection , 1998, Annals of Internal Medicine.

[26]  J. Toouli,et al.  Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. , 1998, Gastroenterology.

[27]  T R Fleming,et al.  Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  J. Houghton,et al.  CEA to detect recurrence of colon cancer. , 1994, JAMA.

[29]  A. Altendorf-Hofmann,et al.  Hepatic metastases from colorectal carcinoma: Impact of surgical resection on the natural history , 1990, The British journal of surgery.

[30]  L. Melton,et al.  Predictors of survival after curative resection of carcinoma of the colon and rectum , 1987, Cancer.